N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide
C26H19FN6O3S — CID 154400821
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide
N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide (PubChem CID 154400821) has the molecular formula C26H19FN6O3S and a molecular weight of 514.54 g/mol. Its IUPAC name is N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide.
Molecular Properties
| Compound Name | N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide |
|---|---|
| PubChem CID | 154400821 |
| Molecular Formula | C26H19FN6O3S |
| Molecular Weight | 514.54 g/mol |
| Exact Mass | 514.12 |
| IUPAC Name | N-[1-carbamoyl-6-[(4-fluorobenzoyl)-methylamino]indol-2-yl]-2-pyridin-4-yl-1,3-thiazole-4-carboxamide |
| SMILES | CN(C(=O)c1ccc(F)cc1)c1ccc2cc(NC(=O)c3csc(-c4ccncc4)n3)n(C(N)=O)c2c1 |
| InChI | InChI=1S/C26H19FN6O3S/c1-32(25(35)16-2-5-18(27)6-3-16)19-7-4-17-12-22(33(26(28)36)21(17)13-19)31-23(34)20-14-37-24(30-20)15-8-10-29-11-9-15/h2-14H,1H3,(H2,28,36)(H,31,34) |
| InChIKey | YDIBAPYMQFAEMD-UHFFFAOYSA-N |
| XLogP | 4.75 |
| TPSA | 123.21 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.54 |
| LogP ≤ 5 | 4.75 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154400821 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.